CoChat
Sign Up
Cited by 318

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Consideration of pathways for immunotoxicity of per-and polyfluoroalkyl substances (PFAS)

Ehrlich, Veronika, Bil, Wieneke, Vandebriel, Rob, Granum, Berit, Luijten, Mirjam, Lindeman, Birgitte, Grandjean, Philippe, Kaiser, Andreas-Marius, Hauzenberger, Ingrid, Hartmann, Christina, Gundacker, Claudia, Uhl, Maria·2023·Environmental Health
DOI 10.1186/s12940-022-00958-5PMC PMC9944481
Open this paper in CoChat — free account

Abstract

Background: Per- and polyfluoroalkyl substances (PFAS) are of public health concern, because of their ubiquitous and extremely persistent occurrence, and depending on their structure, their bio-accumulative, mobile and toxic properties. Human health effects associated with exposure to PFAS include adverse effects on the immune system. In 2020, EFSA (the European Food Safety Authority) defined adverse effects on the immune system as the most critical effect for human health risk assessment, based on reduced antibody responses to childhood vaccines and similar effects observed in experimental animal studies. Likewise, the U.S. EPA (Environmental Protection Agency) considers PFAS-induced immunotoxicity, especially in children, as the critical effect for risk assessment. However, the mechanisms by which antibody concentrations are impacted are not completely understood. Furthermore, other targets of the immune system functions have been reported in the literature. Objective: The aim of this review is to explore PFAS-associated immune-related effects. This includes, relevant mechanisms that may underlie the observed effects on the immune system, immunosuppression as well as immunoenhancement, such as i) modulation of cell signalling and nuclear receptors, such as NF-κB and PPARs; ii) alteration of calcium signalling and homoeostasis in immune cells; iii) modulation of immune cell populations; iv) oxidative stress and v) impact on fatty acid metabolism & secondary effects on the immune system. Methods: A literature research was conducted using three databases (Web of Science, PubMed, and Scopus), which were searched in July 2021 for relevant studies published in the time frame from 2018 to 2021. In total, 487 publications were identified as potentially eligible and following expert-based judgement, articles relevant for mechanisms of PFAS induced immunotoxicity are discussed. Conclusions: Taken together, we show that there is substantial evidence from both in vitro and in vivo experimental as well as epidemiological studies, supporting that various PFAS, not only PFOA and PFOS, affect multiple aspects of the immune system. Timing of exposure is critical, because the developing immune system is especially vulnerable to toxic insults, resulting in a higher risk of particularly adverse immune effects but also other organs later in life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12940-022-00958-5

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 15 references

Research works printed but not linked: 209

  1. OECD (Organisation for Economic Co-operation and Development). Reconciling terminology of the universe of per- and polyfluoroalkyl substances: recommendations and practical guidance. In: OECD environment, health and safety publications series on risk management; 2021. p. 61.
  2. OECD (Organisation for Economic Co-operation and Development). Toward a new comprehensive global database of per- and polyfluoroalkyl substances (PFASs): summary report on updating the OECD 2007 List of per- and polyfluoroalkyl substances (PFASs). In: OECD environment, health and safety publications series on risk management; 2018. p. 39.
  3. Glüge J, London R, Cousins IT, DeWitt J, Goldenman G, Herzke D, et al. Information requirements under the essential-use concept: PFAS case studies. Environ Sci Technol. 2021. https://doi.org/10.1021/acs.est.1c03732. · DOI
  4. Chen M, Guo T, He K, Zhu L, Jin H, Wang Q, et al. Biotransformation and bioconcentration of 6:2 and 8:2 polyfluoroalkyl phosphate diesters in common carp (Cyprinus carpio): underestimated ecological risks. Sci Total Environ. 2019;656:201–8. https://doi.org/10.1016/j.scitotenv.2018.11.297. · DOI
  5. Fenton SE, Ducatman A, Boobis A, DeWitt JC, Lau C, Ng C, et al. Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research. Environ Toxicol Chem. 2021;40:606–30. https://doi.org/10.1002/etc.4890. · DOI · Paper page
  6. von Holst H, Nayak P, Dembek Z, Buehler S, Echeverria D, Fallacara D, et al. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies. Heliyon. 2021;7:e08160. https://doi.org/10.1016/j.heliyon.2021.e08160. · DOI · Paper page
  7. Dalsager L, Christensen N, Halekoh U, Timmermann CAG, Nielsen F, Kyhl HB, et al. Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: a study among 1,503 children from the Odense child cohort. Environ Int. 2021;149:106395. https://doi.org/10.1016/j.envint.2021.106395. · DOI
  8. WHO (World Health Organization). International programme on chemical safety. Guidence for immunotoxicity risk assessment for chemicals: harmonization project document no. 10. 978th ed; 2012.
  9. Skaggs H, Chellman GJ, Collinge M, Enright B, Fuller CL, Krayer J, et al. Comparison of immune system development in nonclinical species and humans: closing information gaps for immunotoxicity testing and human translatability. Reprod Toxicol. 2019;89:178–88. https://doi.org/10.1016/j.reprotox.2019.06.005. · DOI
  10. DeWitt JC, Peden-Adams MM, Keil DE, Dietert RR. Current status of developmental Immunotoxicity: early-life patterns and testing. Toxicol Pathol. 2011;40:230–6. https://doi.org/10.1177/0192623311427709. · DOI
  11. Dietert RR, Piepenbrink MS. Perinatal immunotoxicity: why adult exposure assessment fails to predict risk. Environ Health Perspect. 2006;114:477–83. https://doi.org/10.1289/ehp.8566. · DOI
  12. Midasch O, Drexler H, Hart N, Beckmann MW, Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int Arch Occup Environ Health. 2007;80:643–8. https://doi.org/10.1007/s00420-006-0165-9. · DOI
  13. Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. Trans-placental transfer of thirteen Perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol. 2011;45:7465–72. https://doi.org/10.1021/es202408a. · DOI
  14. Liang L, Pan Y, Bin L, Liu Y, Huang W, Li R, et al. Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS. Chemosphere. 2022;291:132892. https://doi.org/10.1016/j.chemosphere.2021.132892. · DOI
  15. ECHA (European Chemicals Agency). Proposal for a restriction: per- and polyfluoroalkyl substances (PFASs) in firefighting foams; 2022.
  16. ECHA (European Chemicals Agency). Registry of restriction intentions until outcome: per- and polyfluoroalkyl substances (PFAS). 2022.
  17. EC (European Commission). Zero pollution action plan: towards zero pollution for air, water and soil. 2021.
  18. EFSA (European Food Safety Authority). Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food. EFSA J. 2018;16:e05194. https://doi.org/10.2903/j.efsa.2018.5194. · DOI
  19. Grandjean P, Andersen EW, Budtz-Jørgensen E, Nielsen F, Mølbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307:391–7. https://doi.org/10.1001/jama.2011.2034. · DOI · Paper page
  20. Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Timmermann A, et al. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol. 2017;14:188–95. https://doi.org/10.1080/1547691X.2017.1360968. · DOI
  21. Grandjean P, Heilmann C, Weihe PAL, Nielsen F, Mogensen UB, Budtz-Jørgensen E. Serum vaccine antibody concentrations in adolescents exposed to Perfluorinated compounds. Environ Health Perspect. 2017;125:77018. https://doi.org/10.1289/EHP275. · DOI
  22. Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, et al. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci. 2014;138:76–88. https://doi.org/10.1093/toxsci/kft269. · DOI
  23. Stein CR, McGovern KJ, Pajak AM, Maglione PJ, Wolff MS. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: national health and nutrition examination survey. Pediatr Res. 2016;79:348–57. https://doi.org/10.1038/pr.2015.213. · DOI
  24. Stein CR, Ge Y, Wolff MS, Ye X, Calafat AM, Kraus T, et al. Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults. Environ Res. 2016;149:171–8. https://doi.org/10.1016/j.envres.2016.05.020. · DOI
  25. Abraham K, Mielke H, Fromme H, Völkel W, Menzel J, Peiser M, et al. Internal exposure to perfluoroalkyl substances (PFASs) and biological markers in 101 healthy 1-year-old children: associations between levels of perfluorooctanoic acid (PFOA) and vaccine response. Arch Toxicol. 2020;94:2131–47. https://doi.org/10.1007/s00204-020-02715-4. · DOI
  26. Granum B, Haug LS, Namork E, Stølevik SB, Thomsen C, Aaberge IS, et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 2013;10:373–9. https://doi.org/10.3109/1547691X.2012.755580. · DOI · Paper page
  27. Timmermann CAG, Jensen KJ, Nielsen F, Budtz-Jørgensen E, van der Klis F, Benn CS, et al. Serum perfluoroalkyl substances, vaccine responses, and morbidity in a cohort of Guinea-Bissau children. Environ Health Perspect. 2020;128:87002. https://doi.org/10.1289/EHP6517. · DOI
  28. Shih Y-H, Blomberg AJ, Bind M-A, Holm D, Nielsen F, Heilmann C, et al. Serum vaccine antibody concentrations in adults exposed to per- and polyfluoroalkyl substances: a birth cohort in the Faroe Islands. J Immunotoxicol. 2021;18:85–92. https://doi.org/10.1080/1547691X.2021.1922957. · DOI
  29. Timmermann CAG, Pedersen HS, Weihe P, Bjerregaard P, Nielsen F, Heilmann C, et al. Concentrations of tetanus and diphtheria antibodies in vaccinated Greenlandic children aged 7-12 years exposed to marine pollutants, a cross sectional study. Environ Res. 2022;203:111712. https://doi.org/10.1016/j.envres.2021.111712. · DOI
  30. Zhang X, Xue L, Deji Z, Wang X, Liu P, Lu J, et al. Effects of exposure to per- and polyfluoroalkyl substances on vaccine antibodies: a systematic review and meta-analysis based on epidemiological studies. Environ Pollut. 2022;306:119442. https://doi.org/10.1016/j.envpol.2022.119442. · DOI
  31. van Beijsterveldt IA, van Zelst BD, de Fluiter KS, van den Berg SA, van der Steen M, Hokken-Koelega AC. Poly- and perfluoroalkyl substances (PFAS) exposure through infant feeding in early life. Environ Int. 2022;164:107274. https://doi.org/10.1016/j.envint.2022.107274. · DOI · Paper page
  32. Wang Z, Shi R, Ding G, Yao Q, Pan C, Gao Y, et al. Association between maternal serum concentration of perfluoroalkyl substances (PFASs) at delivery and acute infectious diseases in infancy. Chemosphere. 2022;289:133235. https://doi.org/10.1016/j.chemosphere.2021.133235. · DOI
  33. Manzano-Salgado CB, Granum B, Lopez-Espinosa M-J, Ballester F, Iñiguez C, Gascón M, et al. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study. Int J Hyg Environ Health. 2019;222:945–54. https://doi.org/10.1016/j.ijheh.2019.06.005. · DOI
  34. Impinen A, Longnecker MP, Nygaard UC, London SJ, Ferguson KK, Haug LS, et al. Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian mother and child (MoBa) cohort. Environ Int. 2019;124:462–72. https://doi.org/10.1016/j.envint.2018.12.041. · DOI
  35. Huang H, Yu K, Zeng X, Chen Q, Liu Q, Zhao Y, et al. Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children. Environ Res. 2020;191:110156. https://doi.org/10.1016/j.envres.2020.110156. · DOI
  36. Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, Høst A, et al. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1-4years among 359 children in the Odense child cohort. Environ Int. 2016;96:58–64. https://doi.org/10.1016/j.envint.2016.08.026. · DOI
  37. Ji J, Song L, Wang J, Yang Z, Yan H, Li T, et al. Association between urinary per- and poly-fluoroalkyl substances and COVID-19 susceptibility. Environ Int. 2021;153:106524. https://doi.org/10.1016/j.envint.2021.106524. · DOI
  38. Nielsen C, Jöud A. Susceptibility to COVID-19 after high exposure to perfluoroalkyl substances from contaminated drinking water: an ecological study from Ronneby, Sweden. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph182010702. · DOI
  39. Averina M, Brox J, Huber S, Furberg A-S, Sørensen M. Serum perfluoroalkyl substances (PFAS) and risk of asthma and various allergies in adolescents. The Tromsø study fit futures in northern Norway. Environ Res. 2019;169:114–21. https://doi.org/10.1016/j.envres.2018.11.005. · DOI
  40. Beck IH, Timmermann CAG, Nielsen F, Schoeters G, Jøhnk C, Kyhl HB, et al. Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense child cohort. Environ Health. 2019;18:97. https://doi.org/10.1186/s12940-019-0541-z. · DOI
  41. Impinen A, Nygaard UC, Lødrup Carlsen KC, Mowinckel P, Carlsen KH, Haug LS, et al. Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood. Environ Res. 2018;160:518–23. https://doi.org/10.1016/j.envres.2017.10.012. · DOI
  42. Smit LAM, Lenters V, Høyer BB, Lindh CH, Pedersen HS, Liermontova I, et al. Prenatal exposure to environmental chemical contaminants and asthma and eczema in school-age children. Allergy. 2015;70:653–60. https://doi.org/10.1111/all.12605. · DOI
  43. Dong G-H, Tung K-Y, Tsai C-H, Liu M-M, Wang D, Liu W, et al. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect. 2013;121:507–13. https://doi.org/10.1289/ehp.1205351. · DOI
  44. Zhu Y, Qin X-D, Zeng X-W, Paul G, Morawska L, Su M-W, et al. Associations of serum perfluoroalkyl acid levels with T-helper cell-specific cytokines in children: by gender and asthma status. Sci Total Environ. 2016;559:166–73. https://doi.org/10.1016/j.scitotenv.2016.03.187. · DOI
  45. Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, Hiatt RA. Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008). Environ Health Perspect. 2014;122:1129–33. https://doi.org/10.1289/ehp.1306606. · DOI
  46. Jackson-Browne MS, Eliot M, Patti M, Spanier AJ, Braun JM. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014. Int J Hyg Environ Health. 2020;229:113565. https://doi.org/10.1016/j.ijheh.2020.113565. · DOI
  47. Gaylord A, Berger KI, Naidu M, Attina TM, Gilbert J, Koshy TT, et al. Serum perfluoroalkyl substances and lung function in adolescents exposed to the world trade center disaster. Environ Res. 2019;172:266–72. https://doi.org/10.1016/j.envres.2019.02.024. · DOI
  48. Timmermann CAG, Budtz-Jørgensen E, Jensen TK, Osuna CE, Petersen MS, Steuerwald U, et al. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J Immunotoxicol. 2017;14:39–49. https://doi.org/10.1080/1547691X.2016.1254306. · DOI
  49. Mattila T, Santonen T, Andersen HR, Katsonouri A, Szigeti T, Uhl M, et al. Scoping review-the association between asthma and environmental chemicals. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph18031323. · DOI
  50. Plitnick LM, Herzyk DJ. The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Methods Mol Biol. 2010;598:159–71. https://doi.org/10.1007/978-1-60761-401-2_11. · DOI
  51. Selgrade MK. Immunotoxicity: the risk is real. Toxicol Sci. 2007;100:328–32. https://doi.org/10.1093/toxsci/kfm244. · DOI
  52. de Guise S, Levin M. Suppression of Th2 cytokines as a potential mechanism for reduced antibody response following PFOA exposure in female B6C3F1 mice. Toxicol Lett. 2021;351:155–62. https://doi.org/10.1016/j.toxlet.2021.09.002. · DOI
  53. Vetvicka V, Vetvickova J. Reversal of perfluorooctanesulfonate-induced immunotoxicity by a glucan-resveratrol-vitamin C combination. Orient Pharm Exp Med. 2013;13:77–84. https://doi.org/10.1007/s13596-013-0105-7. · DOI
  54. Loveless SE, Hoban D, Sykes G, Frame SR, Everds NE. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol Sci. 2008;105:86–96. https://doi.org/10.1093/toxsci/kfn113. · DOI
  55. DeWitt JC, Copeland CB, Strynar MJ, Luebke RW. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect. 2008;116:644–50. https://doi.org/10.1289/ehp.10896. · DOI
  56. DeWitt JC, Copeland CB, Luebke RW. Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. Toxicol Sci. 2009;109:106–12. https://doi.org/10.1093/toxsci/kfp040. · DOI
  57. DeWitt JC, Williams WC, Creech NJ, Luebke RW. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: role of PPARα and T- and B-cell targeting. J Immunotoxicol. 2016;13:38–45. https://doi.org/10.3109/1547691X.2014.996682. · DOI
  58. Yang Q, Abedi-Valugerdi M, Xie Y, Zhao X-Y, Möller G, Dean Nelson B, et al. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol. 2002;2:389–97. https://doi.org/10.1016/S1567-5769(01)00164-3. · DOI
  59. Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 2008;104:144–54. https://doi.org/10.1093/toxsci/kfn059. · DOI
  60. Zheng L, Dong G-H, Jin Y-H, He Q-C. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch Toxicol. 2009;83:679–89. https://doi.org/10.1007/s00204-008-0361-3. · DOI
  61. Dong G-H, Zhang Y-H, Zheng L, Liu W, Jin Y-H, He Q-C. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch Toxicol. 2009;83:805–15. https://doi.org/10.1007/s00204-009-0424-0. · DOI
  62. Dong G-H, Liu M-M, Wang D, Zheng L, Liang Z-F, Jin Y-H. Sub-chronic effect of perfluorooctanesulfonate (PFOS) on the balance of type 1 and type 2 cytokine in adult C57BL6 mice. Arch Toxicol. 2011;85:1235–44. https://doi.org/10.1007/s00204-011-0661-x. · DOI
  63. Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol Sci. 2008;103:77–85. https://doi.org/10.1093/toxsci/kfn015. · DOI
  64. Lefebvre DE, Curran I, Armstrong C, Coady L, Parenteau M, Liston V, et al. Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats. J Toxicol Environ Health A. 2008;71:1516–25. https://doi.org/10.1080/15287390802391943. · DOI
  65. Rushing BR, Hu Q, Franklin JN, McMahen R, Dagnino S, Higgins CP, et al. Evaluation of the immunomodulatory effects of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in C57BL/6 mice. Toxicol Sci. 2017. https://doi.org/10.1093/toxsci/kfw251. · DOI
  66. McDonough CA, Ward C, Hu Q, Vance S, Higgins CP, DeWitt JC. Immunotoxicity of an electrochemically fluorinated aqueous film-forming foam. Toxicol Sci. 2020;178:104–14. https://doi.org/10.1093/toxsci/kfaa138. · DOI
  67. Qazi MR, Nelson BD, DePierre JW, Abedi-Valugerdi M. 28-day dietary exposure of mice to a low total dose (7 mg/kg) of perfluorooctanesulfonate (PFOS) alters neither the cellular compositions of the thymus and spleen nor humoral immune responses: does the route of administration play a pivotal role in PFOS-induced immunotoxicity? Toxicology. 2010;267:132–9. https://doi.org/10.1016/j.tox.2009.10.035. · DOI
  68. Woodlief T, Vance S, Hu Q, DeWitt J. Immunotoxicity of per- and polyfluoroalkyl substances: insights into short-chain PFAS exposure. Toxics. 2021. https://doi.org/10.3390/toxics9050100. · DOI
  69. Ramhøj L. Developmental toxicity of perfluorohexane sulfonate (PFHxS) - effects on the immune and thyroid hormone systems: Technical University of Denmark; 2018.
  70. Torres L, Redko A, Limper C, Imbiakha B, Chang S, August A. Effect of perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice. Immunol Lett. 2021;233:31–41. https://doi.org/10.1016/j.imlet.2021.03.006. · DOI
  71. Frawley RP, Smith M, Cesta MF, Hayes-Bouknight S, Blystone C, Kissling GE, et al. Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days. J Immunotoxicol. 2018;15:41–52. https://doi.org/10.1080/1547691X.2018.1445145. · DOI
  72. Suo C, Fan Z, Zhou L, Qiu J. Perfluorooctane sulfonate affects intestinal immunity against bacterial infection. Sci Rep. 2017;7:5166. https://doi.org/10.1038/s41598-017-04091-z. · DOI
  73. NTP (National Toxicology Program). TOX-96: 1-perfluorobutanesulfonic acid (375-73-5), potassium perfluorohexanesulfonate (3871-99-6), perfluorooctane sulfonate (1763-23-1), WY-14643 (50892-23-4): Chemical Effects in Biological Systems (CEBS); 2019.
  74. Lieder PH, Chang S-C, York RG, Butenhoff JL. Toxicological evaluation of potassium perfluorobutanesulfonate in a 90-day oral gavage study with Sprague-Dawley rats. Toxicology. 2009;255:45–52. https://doi.org/10.1016/j.tox.2008.10.002. · DOI · Paper page
  75. NTP (National Toxicology Program). TOX-97: perfluorohexanoic acid (307-24-4), perfluorooctanoic acid (335-67-1), perfluorononanoic acid (375-95-1), perfluorodecanoic acid (335-76-2), WY-14643 (50892-23-4): Chemical Effects in Biological Systems (CEBS); 2019.
  76. Loveless SE, Slezak B, Serex T, Lewis J, Mukerji P, O’Connor JC, et al. Toxicological evaluation of sodium perfluorohexanoate. Toxicology. 2009;264:32–44. https://doi.org/10.1016/j.tox.2009.07.011. · DOI
  77. Takahashi M, Ishida S, Hirata-Koizumi M, Ono A, Hirose A. Repeated dose and reproductive/developmental toxicity of perfluoroundecanoic acid in rats. J Toxicol Sci. 2014;39:97–108. https://doi.org/10.2131/jts.39.97. · DOI
  78. Kato H, Fujii S, Takahashi M, Matsumoto M, Hirata-Koizumi M, Ono A, et al. Repeated dose and reproductive/developmental toxicity of perfluorododecanoic acid in rats. Environ Toxicol. 2015;30:1244–63. https://doi.org/10.1002/tox.21996. · DOI
  79. Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology. 2009;262:207–14. https://doi.org/10.1016/j.tox.2009.06.010. · DOI
  80. Wu XM, Bennett DH, Calafat AM, Kato K, Strynar M, Andersen E, et al. Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California. Environ Res. 2015;136:264–73. https://doi.org/10.1016/j.envres.2014.09.026. · DOI
  81. Zhang Y-H, Wang J, Dong G-H, Liu M-M, Wang D, Zheng L, et al. Mechanism of perfluorooctanesulfonate (PFOS)-induced apoptosis in the immunocyte. J Immunotoxicol. 2013;10:49–58. https://doi.org/10.3109/1547691X.2012.691123. · DOI
  82. Fang X, Zhang L, Feng Y, Zhao Y, Dai J. Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol Sci. 2008;105:312–21. https://doi.org/10.1093/toxsci/kfn127. · DOI
  83. Fang X, Feng Y, Shi Z, Dai J. Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. Toxicol Sci. 2009;108:367–76. https://doi.org/10.1093/toxsci/kfp019. · DOI
  84. Kirkpatrick JB. A combined 28-day repeated dose oral toxicity study with the reproduction/developmental toxicity screening test of perfluorohexanoic acid and 1H, 1H, 2H, 2H-tridecafluoro-1-octanol in rats, with recovery: Final Report. WIL-534001. WIL Research Laboratories, LLC. 2005;Volume 1 of 6. p. 1–75.
  85. Rockwell CE, Turley AE, Cheng X, Fields PE, Klaassen CD. Persistent alterations in immune cell populations and function from a single dose of perfluorononanoic acid (PFNA) in C57Bl/6 mice. Food Chem Toxicol. 2017;100:24–33. https://doi.org/10.1016/j.fct.2016.12.004. · DOI
  86. Rockwell CE, Turley AE, Cheng X, Fields PE, Klaassen CD. Acute Immunotoxic effects of perfluorononanoic acid (PFNA) in C57BL/6 mice. Clin Exp Pharmacol. 2013. https://doi.org/10.4172/2161-1459.S4-002. · DOI
  87. Nian M, Zhou W, Feng Y, Wang Y, Chen Q, Zhang J. Emerging and legacy PFAS and cytokine homeostasis in women of childbearing age. Sci Rep. 2022;12:6517. https://doi.org/10.1038/s41598-022-10501-8. · DOI
  88. Matta K, Lefebvre T, Vigneau E, Cariou V, Marchand P, Guitton Y, et al. Associations between persistent organic pollutants and endometriosis: a multiblock approach integrating metabolic and cytokine profiling. Environ Int. 2022;158:106926. https://doi.org/10.1016/j.envint.2021.106926. · DOI
  89. Papadopoulou E, Stratakis N, Basagaña X, Brantsæter AL, Casas M, Fossati S, et al. Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts. Environ Int. 2021;157:106853. https://doi.org/10.1016/j.envint.2021.106853. · DOI
  90. Zota AR, Geller RJ, Romano LE, Coleman-Phox K, Adler NE, Parry E, et al. Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular aging during pregnancy and postpartum. Environ Int. 2018;115:9–20. https://doi.org/10.1016/j.envint.2018.02.044. · DOI
  91. Oulhote Y, Shamim Z, Kielsen K, Weihe P, Grandjean P, Ryder LP, et al. Children’s white blood cell counts in relation to developmental exposures to methylmercury and persistent organic pollutants. Reprod Toxicol. 2017;68:207–14. https://doi.org/10.1016/j.reprotox.2016.08.001. · DOI
  92. Knudsen A-KS, Long M, Pedersen HS, Bonefeld-Jørgensen EC. Persistent organic pollutants and haematological markers in Greenlandic pregnant women: the ACCEPT sub-study. Int J Circumpolar Health. 2018;77:1456303. https://doi.org/10.1080/22423982.2018.1456303. · DOI
  93. Lopez-Espinosa M-J, Carrizosa C, Luster MI, Margolick JB, Costa O, Leonardi GS, et al. Perfluoroalkyl substances and immune cell counts in adults from the mid-Ohio Valley (USA). Environ Int. 2021;156:106599. https://doi.org/10.1016/j.envint.2021.106599. · DOI
  94. Son H-Y, Lee S, Tak E-N, Cho H-S, Shin H-I, Kim S-H, et al. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environ Toxicol. 2009;24:580–8. https://doi.org/10.1002/tox.20459. · DOI
  95. Yang Q, Xie Y, Eriksson AM, Nelson BD, DePierre JW. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem Pharmacol. 2001;62:1133–40. https://doi.org/10.1016/s0006-2952(01)00752-3. · DOI
  96. Qazi MR, Dean Nelson B, DePierre JW, Abedi-Valugerdi M. High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells in the bone marrow and these effects are partially dependent on reduced food consumption. Food Chem Toxicol. 2012;50:2955–63. https://doi.org/10.1016/j.fct.2012.06.023. · DOI
  97. Hu Q, Franklin JN, Bryan I, Morris E, Wood A, DeWitt JC. Does developmental exposure to perfluorooctanoic acid (PFOA) induce immunopathologies commonly observed in neurodevelopmental disorders? Neurotoxicology. 2012;33:1491–8. https://doi.org/10.1016/j.neuro.2012.10.016. · DOI
  98. Fragki S, Dirven H, Fletcher T, Grasl-Kraupp B, Bjerve Gützkow K, Hoogenboom R, et al. Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not? Crit Rev Toxicol. 2021;51:141–64. https://doi.org/10.1080/10408444.2021.1888073. · DOI
  99. Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https://doi.org/10.1038/sigtrans.2017.23. · DOI · Paper page
  100. Lee J-K, Kim S-H. Correlation between mast cell-mediated allergic inflammation and length of perfluorinated compounds. J Toxicol Environ Health A. 2018;81:302–13. https://doi.org/10.1080/15287394.2018.1440188. · DOI
  101. Zhang H, Fang W, Wang D, Gao N, Ding Y, Chen C. The role of interleukin family in perfluorooctanoic acid (PFOA)-induced immunotoxicity. J Hazard Mater. 2014;280:552–60. https://doi.org/10.1016/j.jhazmat.2014.08.043. · DOI
  102. Kunicka Z, Kurzyńska A, Szydłowska A, Kaczyńska B, Bogacka I. PPARβ/δ ligands regulate the expression of immune response mediators in the porcine endometrium - an in vitro study. Theriogenology. 2019;134:112–20. https://doi.org/10.1016/j.theriogenology.2019.05.022. · DOI
  103. Christofides A, Konstantinidou E, Jani C, Boussiotis VA. The role of peroxisome proliferator-activated receptors (PPAR) in immune responses. Metabolism. 2021;114:154338. https://doi.org/10.1016/j.metabol.2020.154338. · DOI
  104. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748–59. https://doi.org/10.1038/nri912. · DOI
  105. Abbott BD. Review of the expression of peroxisome proliferator-activated receptors alpha (PPAR alpha), beta (PPAR beta), and gamma (PPAR gamma) in rodent and human development. Reprod Toxicol. 2009;27:246–57. https://doi.org/10.1016/j.reprotox.2008.10.001. · DOI
  106. Korbecki J, Bobiński R, Dutka M. Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors. Inflamm Res. 2019;68:443–58. https://doi.org/10.1007/s00011-019-01231-1. · DOI · Paper page
  107. Schlezinger JJ, Puckett H, Oliver J, Nielsen G, Heiger-Bernays W, Webster TF. Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet. Toxicol Appl Pharmacol. 2020;405:115204. https://doi.org/10.1016/j.taap.2020.115204. · DOI
  108. Pennings JLA, Jennen DGJ, Nygaard UC, Namork E, Haug LS, van Loveren H, et al. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol. 2016;13:173–80. https://doi.org/10.3109/1547691X.2015.1029147. · DOI
  109. Conley JM, Lambright CS, Evans N, McCord J, Strynar MJ, Hill D, et al. Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat. Environ Int. 2021;146:106204. https://doi.org/10.1016/j.envint.2020.106204. · DOI
  110. Li C-H, Ren X-M, Ruan T, Cao L-Y, Xin Y, Guo L-H, et al. Chlorinated polyfluorinated ether sulfonates exhibit higher activity toward peroxisome proliferator-activated receptors signaling pathways than perfluorooctanesulfonate. Environ Sci Technol. 2018;52:3232–9. https://doi.org/10.1021/acs.est.7b06327. · DOI
  111. Croasdell A, Duffney PF, Kim N, Lacy SH, Sime PJ, Phipps RP. PPARγ and the innate immune system mediate the resolution of inflammation. PPAR Res. 2015;2015:549691. https://doi.org/10.1155/2015/549691. · DOI
  112. Nobs SP, Kopf M. PPAR-γ in innate and adaptive lung immunity. J Leukoc Biol. 2018;104:737–41. https://doi.org/10.1002/JLB.3MR0118-034R. · DOI
  113. Pawliczak R, Logun C, Madara P, Lawrence M, Woszczek G, Ptasinska A, et al. Cytosolic phospholipase A2 group IValpha but not secreted phospholipase A2 group IIA, V, or X induces interleukin-8 and cyclooxygenase-2 gene and protein expression through peroxisome proliferator-activated receptors gamma 1 and 2 in human lung cells. J Biol Chem. 2004;279:48550–61. https://doi.org/10.1074/jbc.M408926200. · DOI
  114. Pontsler AV, St Hilaire A, Marathe GK, Zimmerman GA, McIntyre TM. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein. J Biol Chem. 2002;277:13029–36. https://doi.org/10.1074/jbc.M109546200. · DOI
  115. AbdelMassih AF, Menshawey R, Ismail JH, Husseiny RJ, Husseiny YM, Yacoub S, et al. PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature. J Genet Eng Biotechnol. 2021;19:82. https://doi.org/10.1186/s43141-021-00179-2. · DOI
  116. Singh TSK, Lee S, Kim H-H, Choi JK, Kim S-H. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators. Toxicol Lett. 2012;210:64–70. https://doi.org/10.1016/j.toxlet.2012.01.014. · DOI
  117. Finlay DK. Regulation of glucose metabolism in T cells: new insight into the role of phosphoinositide 3-kinases. Front Immunol. 2012;3:247. https://doi.org/10.3389/fimmu.2012.00247. · DOI
  118. Staud F, Karahoda R. Trophoblast: the central unit of fetal growth, protection and programming. Int J Biochem Cell Biol. 2018;105:35–40. https://doi.org/10.1016/j.biocel.2018.09.016. · DOI
  119. Bogacka I, Kurzynska A, Bogacki M, Chojnowska K. Peroxisome proliferator-activated receptors in the regulation of female reproductive functions. Folia Histochem Cytobiol. 2015;53:189–200. https://doi.org/10.5603/fhc.a2015.0023. · DOI
  120. Koskela A, Koponen J, Lehenkari P, Viluksela M, Korkalainen M, Tuukkanen J. Perfluoroalkyl substances in human bone: concentrations in bones and effects on bone cell differentiation. Sci Rep. 2017;7:6841. https://doi.org/10.1038/s41598-017-07359-6. · DOI
  121. Bogdanska J, Sundström M, Bergström U, Borg D, Abedi-Valugerdi M, Bergman Å, et al. Tissue distribution of 35S-labelled perfluorobutanesulfonic acid in adult mice following dietary exposure for 1-5 days. Chemosphere. 2014;98:28–36. https://doi.org/10.1016/j.chemosphere.2013.09.062. · DOI
  122. Kirk AB, Michelsen-Correa S, Rosen C, Martin CF, Blumberg B. PFAS and potential adverse effects on bone and adipose tissue through interactions with PPARγ. Endocrinology. 2021;162:bqab194. https://doi.org/10.1210/endocr/bqab194. · DOI · Paper page
  123. Pérez F, Nadal M, Navarro-Ortega A, Fàbrega F, Domingo JL, Barceló D, et al. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 2013;59:354–62. https://doi.org/10.1016/j.envint.2013.06.004. · DOI · Paper page
  124. Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism. Fundam Clin Pharmacol. 2007;21:231–44. https://doi.org/10.1111/j.1472-8206.2007.00486.x. · DOI
  125. Madel M-B, Ibáñez L, Wakkach A, de Vries TJ, Teti A, Apparailly F, et al. Immune function and diversity of osteoclasts in normal and pathological conditions. Front Immunol. 2019;10:1408. https://doi.org/10.3389/fimmu.2019.01408. · DOI
  126. Liu W, Qin H, Pan Y, Luo F, Zhang Z. Low concentrations of perfluorooctane sulfonate repress osteogenic and enhance adipogenic differentiation of human mesenchymal stem cells. Toxicol Appl Pharmacol. 2019;367:82–91. https://doi.org/10.1016/j.taap.2019.02.001. · DOI
  127. Heikkinen S, Auwerx J, Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta. 2007;1771:999–1013. https://doi.org/10.1016/j.bbalip.2007.03.006. · DOI
  128. Villa A, Vezzoni P, Frattini A. Osteopetroses and immunodeficiencies in humans. Curr Opin Allergy Clin Immunol. 2006;6:421–7. https://doi.org/10.1097/01.all.0000246620.26623.5b. · DOI
  129. Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5. https://doi.org/10.1186/1750-1172-4-5. · DOI
  130. O'Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553–65. https://doi.org/10.1038/nri.2016.70. · DOI · Paper page
  131. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT-H, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol. 2011;12:408–15. https://doi.org/10.1038/ni.2022. · DOI · Paper page
  132. Shih Y-H, Blomberg AJ, Jørgensen LH, Weihe P, Grandjean P. Early-life exposure to perfluoroalkyl substances in relation to serum adipokines in a longitudinal birth cohort. Environ Res. 2022;204:111905. https://doi.org/10.1016/j.envres.2021.111905. · DOI
  133. Houck KA, Patlewicz G, Richard AM, Williams AJ, Shobair MA, Smeltz M, et al. Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure. Toxicology. 2021;457:152789. https://doi.org/10.1016/j.tox.2021.152789. · DOI
  134. Li C-H, Shi Y-L, Li M, Guo L-H, Cai Y-Q. Receptor-bound perfluoroalkyl carboxylic acids dictate their activity on human and mouse peroxisome proliferator-activated receptor γ. Environ Sci Technol. 2020;54:9529–36. https://doi.org/10.1021/acs.est.0c02386. · DOI
  135. Zhang L, Ren X-M, Wan B, Guo L-H. Structure-dependent binding and activation of perfluorinated compounds on human peroxisome proliferator-activated receptor γ. Toxicol Appl Pharmacol. 2014;279:275–83. https://doi.org/10.1016/j.taap.2014.06.020. · DOI
  136. Trebak M, Kinet J-P. Calcium signalling in T cells. Nat Rev Immunol. 2019;19:154–69. https://doi.org/10.1038/s41577-018-0110-7. · DOI
  137. Bohmwald K, Gálvez NMS, Andrade CA, Mora VP, Muñoz JT, González PA, et al. Modulation of adaptive immunity and viral infections by ion channels. Front Physiol. 2021:12. · DOI
  138. Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol. 2015;33:291–353. https://doi.org/10.1146/annurev-immunol-032414-112212. · DOI
  139. Holsapple MP, Karras JG, Ledbetter JA, Schieven GL, Burchiel SW, Davila DR, et al. Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers. Annu Rev Pharmacol Toxicol. 1996;36:131–59. https://doi.org/10.1146/annurev.pa.36.040196.001023. · DOI
  140. Krieger JA, Davila DR, Lytton J, Born JL, Burchiel SW. Inhibition of sarcoplasmic/endoplasmic reticulum calcium ATPases (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human T cells and other tissues. Toxicol Appl Pharmacol. 1995;133:102–8. https://doi.org/10.1006/taap.1995.1131. · DOI
  141. Mounho BJ, Burchiel SW. Alterations in human B cell calcium homeostasis by polycyclic aromatic hydrocarbons: possible associations with cytochrome P450 metabolism and increased protein tyrosine phosphorylation. Toxicol Appl Pharmacol. 1998;149:80–9. https://doi.org/10.1006/taap.1997.8345. · DOI
  142. Gao J, Voss AA, Pessah IN, Lauer FT, Penning TM, Burchiel SW. Ryanodine receptor-mediated rapid increase in intracellular calcium induced by 7,8-benzo(a)pyrene Quinone in human and murine leukocytes. Toxicol Sci. 2005;87:419–26. https://doi.org/10.1093/toxsci/kfi265. · DOI
  143. Kobayashi D, Ahmed S, Ishida M, Kasai S, Kikuchi H. Calcium/calmodulin signaling elicits release of cytochrome c during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced apoptosis in the human lymphoblastic T-cell line, L-MAT. Toxicology. 2009;258:25–32. https://doi.org/10.1016/j.tox.2009.01.002. · DOI
  144. Wang L-Q, Liu T, Yang S, Sun L, Zhao Z-Y, Li L-Y, et al. Perfluoroalkyl substance pollutants activate the innate immune system through the AIM2 inflammasome. Nat Commun. 2021;12:2915. https://doi.org/10.1038/s41467-021-23201-0. · DOI
  145. Lee J-K, Lee S, Baek M-C, Lee B-H, Lee H-S, Kwon TK, et al. Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation. J Appl Toxicol. 2017;37:554–62. https://doi.org/10.1002/jat.3389. · DOI
  146. Lee J-K, Lee S, Choi Y-A, Jin M, Kim Y-Y, Kang B-C, et al. Perfluorooctane sulfonate exacerbates mast cell-mediated allergic inflammation by the release of histamine. Mol Cell Toxicol. 2018;14:173–81. https://doi.org/10.1007/s13273-018-0019-z. · DOI
  147. Suzuki Y, Inoue T, Ra C. Calcium signaling in mast cells: focusing on L-type calcium channels. In: Islam MS, editor. Calcium signaling. Dordrecht: Springer Netherlands; 2012. p. 955–77. https://doi.org/10.1007/978-94-007-2888-2_44. · DOI
  148. Chen Y-C, Chang Y-C, Chang H-A, Lin Y-S, Tsao C-W, Shen M-R, et al. Differential Ca2+ mobilization and mast cell degranulation by FcεRI- and GPCR-mediated signaling. Cell Calcium. 2017;67:31–9. https://doi.org/10.1016/j.ceca.2017.08.002. · DOI
  149. Pan Y, Qin H, Liu W, Zhang Q, Zheng L, Zhou C, et al. Effects of chlorinated polyfluoroalkyl ether sulfonate in comparison with perfluoroalkyl acids on gene profiles and stemness in human mesenchymal stem cells. Chemosphere. 2019;237:124402. https://doi.org/10.1016/j.chemosphere.2019.124402. · DOI
  150. Berntsen HF, Bjørklund CG, Strandabø R, Haug TM, Moldes-Anaya A, Fuentes-Lazaro J, et al. PFOS-induced excitotoxicity is dependent on Ca2+ influx via NMDA receptors in rat cerebellar granule neurons. Toxicol Appl Pharmacol. 2018;357:19–32. https://doi.org/10.1016/j.taap.2018.08.015. · DOI
  151. Harada K, Xu F, Ono K, Iijima T, Koizumi A. Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. Biochem Biophys Res Commun. 2005;329:487–94. https://doi.org/10.1016/j.bbrc.2005.01.163. · DOI
  152. Gundacker C, Audouze K, Widhalm R, Granitzer S, Forsthuber M, Jornod F, et al. Reduced birth weight and exposure to per- and polyfluoroalkyl substances: a review of possible underlying mechanisms using the AOP-helpFinder. Toxics. 2022;10(11):684. https://doi.org/10.3390/toxics10110684. Accepted 10 Nov 2022. · DOI
  153. Iwasaki Y, Takeshima Y, Fujio K. Basic mechanism of immune system activation by mitochondria. Immunol Med. 2020;43:142–7. https://doi.org/10.1080/25785826.2020.1756609. · DOI
  154. Liu Q, Zhang D, Hu D, Zhou X, Zhou Y. The role of mitochondria in NLRP3 inflammasome activation. Mol Immunol. 2018;103:115–24. https://doi.org/10.1016/j.molimm.2018.09.010. · DOI · Paper page
  155. Zarei MH, Hosseini Shirazi SF, Aghvami M, Pourahmad J. Perfluorooctanesulfonate (PFOS) induces apoptosis signaling and proteolysis in human lymphocytes through ROS mediated mitochondrial dysfunction and lysosomal membrane labialization. Iran J Pharm Res. 2018;17:995–1007.
  156. Alharthy SA, Hardej D. The role of transcription factor Nrf2 in the toxicity of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in C57BL/6 mouse astrocytes. Environ Toxicol Pharmacol. 2021;86:103652. https://doi.org/10.1016/j.etap.2021.103652. · DOI
  157. Xu M, Wan J, Niu Q, Liu R. PFOA and PFOS interact with superoxide dismutase and induce cytotoxicity in mouse primary hepatocytes: a combined cellular and molecular methods. Environ Res. 2019;175:63–70. https://doi.org/10.1016/j.envres.2019.05.008. · DOI
  158. Lv Z, Wu W, Ge S, Jia R, Lin T, Yuan Y, et al. Naringin protects against perfluorooctane sulfonate-induced liver injury by modulating NRF2 and NF-κB in mice. Int Immunopharmacol. 2018;65:140–7. https://doi.org/10.1016/j.intimp.2018.09.019. · DOI
  159. Pan X, Qin P, Liu R, Yu W, Dong X. Effects of carbon chain length on the perfluoroalkyl acids-induced oxidative stress of erythrocytes in vitro. J Agric Food Chem. 2018;66:6414–20. https://doi.org/10.1021/acs.jafc.8b02197. · DOI
  160. Jiang W, Deng Y, Song Z, Xie Y, Gong L, Chen Y, et al. Gestational perfluorooctanoic acid exposure inhibits placental development by dysregulation of labyrinth vessels and uNK cells and apoptosis in mice. Front Physiol. 2020. https://doi.org/10.3389/fphys.2020.00051. · DOI
  161. Brieger A, Bienefeld N, Hasan R, Goerlich R, Haase H. Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. Toxicol in Vitro. 2011;25:960–8. https://doi.org/10.1016/j.tiv.2011.03.005. · DOI
  162. Pallmer K, Oxenius A. Recognition and regulation of T cells by NK cells. Front Immunol. 2016;7:251. https://doi.org/10.3389/fimmu.2016.00251. · DOI
  163. Peyton Myers L. Clinical immunotoxicology. Methods Mol Biol. 1803;2018:15–26. https://doi.org/10.1007/978-1-4939-8549-4_2. · DOI
  164. Ryu MH, Jha A, Ojo OO, Mahood TH, Basu S, Detillieux KA, et al. Chronic exposure to perfluorinated compounds: impact on airway hyperresponsiveness and inflammation. Am J Physiol Lung Cell Mol Physiol. 2014;307:L765–74. https://doi.org/10.1152/ajplung.00100.2014. · DOI
  165. Fairley KJ, Purdy R, Kearns S, Anderson SE, Meade BJ. Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin. Toxicol Sci. 2007;97:375–83. https://doi.org/10.1093/toxsci/kfm053. · DOI
  166. Yang M, Li L-Y, Qin X-D, Ye X-Y, Yu S, Bao Q, et al. Perfluorooctanesulfonate and perfluorooctanoate exacerbate airway inflammation in asthmatic mice and in vitro. Sci Total Environ. 2021;766:142365. https://doi.org/10.1016/j.scitotenv.2020.142365. · DOI
  167. Zeng Z, Ma W, Zhao R, Dong X. Airway exposure to perfluorooctanoate exacerbates airway hyperresponsiveness and downregulates glucocorticoid receptor expression in asthmatic mice. Transl Pediatr. 2021;10:323–32. https://doi.org/10.21037/tp-20-246. · DOI
  168. Park S-J, Sim KH, Shrestha P, Yang J-H, Lee YJ. Perfluorooctane sulfonate and bisphenol a induce a similar level of mast cell activation via a common signaling pathway, Fyn-Lyn-Syk activation. Food Chem Toxicol. 2021;156:112478. https://doi.org/10.1016/j.fct.2021.112478. · DOI
  169. Wang M, Li Q, Hou M, Chan LL, Liu M, Ter SK, et al. Inactivation of common airborne antigens by perfluoroalkyl chemicals modulates early life allergic asthma. Proc Natl Acad Sci. 2021;118:e2011957118. https://doi.org/10.1073/pnas.2011957118. · DOI
  170. Steenland K, Zhao L, Winquist A, Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect. 2013;121:900–5. https://doi.org/10.1289/ehp.1206449. · DOI
  171. Steenland K, Zhao L, Winquist A. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occup Environ Med. 2015;72:373–80. https://doi.org/10.1136/oemed-2014-102364. · DOI
  172. Steenland K, Fletcher T, Stein CR, Bartell SM, Darrow L, Lopez-Espinosa M-J, et al. Review: evolution of evidence on PFOA and health following the assessments of the C8 science panel. Environ Int. 2020;145:106125. https://doi.org/10.1016/j.envint.2020.106125. · DOI
  173. Lochhead P, Khalili H, Ananthakrishnan AN, Burke KE, Richter JM, Sun Q, et al. Plasma concentrations of perfluoroalkyl substances and risk of inflammatory bowel diseases in women: a nested case control analysis in the nurses’ health study cohorts. Environ Res. 2022;207:112222. https://doi.org/10.1016/j.envres.2021.112222. · DOI
  174. Bodin J, Groeng E-C, Andreassen M, Dirven H, Nygaard UC. Exposure to perfluoroundecanoic acid (PFUnDA) accelerates insulitis development in a mouse model of type 1 diabetes. Toxicol Rep. 2016;3:664–72. https://doi.org/10.1016/j.toxrep.2016.08.009. · DOI · Paper page
  175. Margolis R, Sant KE. Associations between exposures to perfluoroalkyl substances and diabetes, hyperglycemia, or insulin resistance: a scoping review; 2021. · DOI · Paper page
  176. Antoniou E, Colnot T, Zeegers M, Dekant W. Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies. Arch Toxicol. 2022;96:2261–85. https://doi.org/10.1007/s00204-022-03303-4. · DOI
  177. Germolec DR, Lebrec H, Anderson SE, Burleson GR, Cardenas A, Corsini E, et al. Consensus on the key characteristics of Immunotoxic agents as a basis for hazard identification. Environ Health Perspect. 2022;130:105001. https://doi.org/10.1289/EHP10800. · DOI
  178. Naidenko OV, Andrews DQ, Temkin AM, Stoiber T, Uche UI, Evans S, et al. Investigating molecular mechanisms of immunotoxicity and the utility of ToxCast for Immunotoxicity screening of chemicals added to food. Int J Environ Res Public Health. 2021. https://doi.org/10.3390/ijerph18073332. · DOI
  179. Pappalardo F, Russo G, Corsini E, Paini A, Worth A. Translatability and transferability of in silico models: context of use switching to predict the effects of environmental chemicals on the immune system. Comput Struct Biotechnol J. 2022;20:1764–77. https://doi.org/10.1016/j.csbj.2022.03.024. · DOI
  180. Bulka CM, Avula V, Fry RC. Associations of exposure to perfluoroalkyl substances individually and in mixtures with persistent infections: recent findings from NHANES 1999-2016. Environ Pollut. 2021;275:116619. https://doi.org/10.1016/j.envpol.2021.116619. · DOI
  181. Kotlarz N, McCord J, Collier D, Lea CS, Strynar M, Lindstrom AB, et al. Measurement of novel, drinking water-associated PFAS in blood from adults and children in Wilmington. North Carolina Environ Health Perspect. 2020;128:77005. https://doi.org/10.1289/EHP6837. · DOI · Paper page
  182. Awad R, Zhou Y, Nyberg E, Namazkar S, Yongning W, Xiao Q, et al. Emerging per- and polyfluoroalkyl substances (PFAS) in human milk from Sweden and China. Environ Sci Processes Impacts. 2020;22:2023–30. https://doi.org/10.1039/D0EM00077A. · DOI
  183. Corsini E, Avogadro A, Galbiati V, dell'Agli M, Marinovich M, Galli CL, et al. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Toxicol Appl Pharmacol. 2011;250:108–16. https://doi.org/10.1016/j.taap.2010.11.004. · DOI
  184. Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, et al. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol. 2012;258:248–55. https://doi.org/10.1016/j.taap.2011.11.004. · DOI
  185. Wang Y, Wang L, Liang Y, Qiu W, Zhang J, Zhou Q, et al. Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. Toxicol Lett. 2011;204:174–82. https://doi.org/10.1016/j.toxlet.2011.04.029. · DOI
  186. Zhou X, Dong T, Fan Z, Peng Y, Zhou R, Wang X, et al. Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells. Sci Rep. 2017;7:45468. https://doi.org/10.1038/srep45468. · DOI
  187. Han R, Zhang F, Wan C, Liu L, Zhong Q, Ding W. Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB/TNF-α/IL-6-dependent pathway. Chemosphere. 2018;200:283–94. https://doi.org/10.1016/j.chemosphere.2018.02.137. · DOI
  188. Park MH, Gutiérrez-García AK, Choudhury M. Mono-(2-ethylhexyl) phthalate aggravates inflammatory response via Sirtuin regulation and Inflammasome activation in RAW 264.7 cells. Chem Res Toxicol. 2019;32:935–42. https://doi.org/10.1021/acs.chemrestox.9b00101. · DOI
  189. Guo J, Wu P, Cao J, Luo Y, Chen J, Wang G, et al. The PFOS disturbed immunomodulatory functions via nuclear factor-κB signaling in liver of zebrafish (Danio rerio). Fish Shellfish Immunol. 2019;91:87–98. https://doi.org/10.1016/j.fsi.2019.05.018. · DOI
  190. Zhong Y, Shen L, Ye X, Zhou D, He Y, Zhang H. Mechanism of immunosuppression in zebrafish (Danio rerio) spleen induced by environmentally relevant concentrations of perfluorooctanoic acid. Chemosphere. 2020;249:126200. https://doi.org/10.1016/j.chemosphere.2020.126200. · DOI
  191. Zhang H, Shen L, Fang W, Zhang X, Zhong Y. Perfluorooctanoic acid-induced immunotoxicity via NF-kappa B pathway in zebrafish (Danio rerio) kidney. Fish Shellfish Immunol. 2021;113:9–19. https://doi.org/10.1016/j.fsi.2021.03.004. · DOI
  192. Fang X, Zou S, Zhao Y, Cui R, Zhang W, Hu J, et al. Kupffer cells suppress perfluorononanoic acid-induced hepatic peroxisome proliferator-activated receptor α expression by releasing cytokines. Arch Toxicol. 2012;86:1515–25. https://doi.org/10.1007/s00204-012-0877-4. · DOI
  193. Zhang W, Wang F, Xu P, Miao C, Zeng X, Cui X, et al. Perfluorooctanoic acid stimulates breast cancer cells invasion and up-regulates matrix metalloproteinase-2/−9 expression mediated by activating NF-κB. Toxicol Lett. 2014;229:118–25. https://doi.org/10.1016/j.toxlet.2014.06.004. · DOI
  194. Zhu J, Qian W, Wang Y, Gao R, Wang J, Xiao H. Involvement of mitogen-activated protein kinase and NF-κB signaling pathways in perfluorooctane sulfonic acid-induced inflammatory reaction in BV2 microglial cells. J Appl Toxicol. 2015;35:1539–49. https://doi.org/10.1002/jat.3119. · DOI
  195. Miao C, Ma J, Zhang Y, Chu Y, Li J, Kuai R, et al. Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/−9 expression. Int J Clin Exp Pathol. 2015;8:10512–22.
  196. Yang J, Wang C, Nie X, Shi S, Xiao J, Ma X, et al. Perfluorooctane sulfonate mediates microglial activation and secretion of TNF-α through Ca2+-dependent PKC-NF-кB signaling. Int Immunopharmacol. 2015;28:52–60. https://doi.org/10.1016/j.intimp.2015.05.019. · DOI
  197. Zhao M, Jiang Q, Wang W, Geng M, Wang M, Han Y, et al. The roles of reactive oxygen species and nitric oxide in Perfluorooctanoic acid-induced developmental cardiotoxicity and l-carnitine mediated protection. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18061229. · DOI
  198. Li X, Bao C, Ma Z, Xu B, Ying X, Liu X, et al. Perfluorooctanoic acid stimulates ovarian cancer cell migration, invasion via ERK/NF-κB/MMP-2/−9 pathway. Toxicol Lett. 2018;294:44–50. https://doi.org/10.1016/j.toxlet.2018.05.009. · DOI
  199. Chen X, Nie X, Mao J, Zhang Y, Yin K, Sun P, et al. Perfluorooctane sulfonate mediates secretion of IL-1β through PI3K/AKT NF-кB pathway in astrocytes. Neurotoxicol Teratol. 2018;67:65–75. https://doi.org/10.1016/j.ntt.2018.03.004. · DOI
  200. Saejia P, Lirdprapamongkol K, Svasti J, Paricharttanakul NM. Perfluorooctanoic acid enhances invasion of follicular thyroid carcinoma cells through NF-κB and matrix Metalloproteinase-2 activation. Anticancer Res. 2019;39:2429–35. https://doi.org/10.21873/anticanres.13360. · DOI

200 of 209 shown

Cited by

Sorted by citations

See all 318

Metadata

Authors
Ehrlich, V., Bil, W., Vandebriel, R., Granum, B., Luijten, M., Lindeman, B., Grandjean, P., Kaiser, A.-M., Hauzenberger, I., Hartmann, C., Gundacker, C., & Uhl, M.
Venue
Environmental Health
Publisher
Springer Science and Business Media LLC
Published
2023-02-22
Volume
22
Issue
1
ISSN
1476-069X
DOI
10.1186/s12940-022-00958-5
PMC
PMC9944481
Cited by
318
References
15
Language
en
Licence
Funders
European Commission (grant agreement No. 733032, HBM4EU project)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review